Companies: 10,795·Total market cap: $144.5T
Candel Therapeutics, Inc.

Candel Therapeutics, Inc.

CADLNASDAQHealthcare● Active
$8.77
+$0.26(+3.06%)
Market Cap$481480744
P/E Ratio
52W High$9.27
52W Low$4.35
Overview

Candel Therapeutics, Inc. (CADL) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CADL · as of Mar 12, 2026

Latest filing snapshot

5
-33-86.84%vs prior year

Candel Therapeutics, Inc. (CADL) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
5
Change (1Y)
-33
Growth % (1Y)
-86.84%
Revenue / Employee
Net Income / Employee
$-7.64M
Market Cap
$481M

CADL Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-125-33-86.84%
2025-03-1338-4-9.52%
2024-03-2842-34-44.74%
2023-03-3076+11+16.92%
2022-03-2965

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Editas Medicine, Inc.
EDIT
Editas Medicine, Inc.
246
#2
Cabaletta Bio, Inc.
CABA
Cabaletta Bio, Inc.
161
#3
Capricor Therapeutics, Inc.
CAPR
Capricor Therapeutics, Inc.
160
#4
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
41
#5
Genelux Corporation
GNLX
Genelux Corporation
24
#6
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc.
9
#7
Candel Therapeutics, Inc.
CADL
Candel Therapeutics, Inc.YOU
5
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CADL peer comparison

About CADL employees

CADL Employees · Headcount

Candel Therapeutics, Inc. (CADL) employee data is sourced from the annual SEC 10-K filing. As of 2025, Candel Therapeutics, Inc. had 5 full-time employees globally. Full-time employees only. Global consolidated headcount.

Candel Therapeutics, Inc.'s workforce decreased by 33 (86.84%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

CADL Employees · 5 questions

As of the latest SEC 10-K filing (2025), Candel Therapeutics, Inc. had 5 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Candel Therapeutics, Inc. employee counthow many employees does Candel Therapeutics, Inc. haveCADL total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12